Whitehead Institute scientists have at last answered the long - standing question of how the growth - regulating pathway known
as mechanistic target of rapamycin complex 1 (mTORC1) detects the presence of the amino acid leucine — itself a key player in modulating muscle growth, appetite, and insulin secretion.
Not exact matches
The
mechanistic modelling, treatment of people
as resources, obsession with the short - term, and management by
targets in the public sector are all symptoms of the sick ideology that has driven management culture, which Simon brilliantly dissected.
To coordinate their size and growth with current environmental conditions, cells rely on the
mechanistic target of rapamycin complex 1 (mTORC1) pathway, which senses cellular stresses, growth factors, and the availability of nutrients, such
as amino acids and glucose.
Known
as much for its complexity
as its vital role in regulating cellular and organismal growth, the
mechanistic target of rapamycin complex 1 (mTORC1) pathway has seemingly been acting in mysterious ways.
This study is good example of a precision medicine themed approach to showing how a
mechanistic understanding of the differential gene expression can yield biomarkers that can be used for early detection of disease,
as well
as potential therapeutic
targets.
Whitehead Institute researchers have elucidated how the growth - regulating metabolic pathway known
as mTORC1 (for
mechanistic target of rapamycin complex 1) senses the amino acid arginine.
BETHESDA, MD, — The Foundation for the National Institutes of Health (FNIH) has selected Whitehead Institute Member David Sabatini to receive its fifth annual Lurie Prize in Biomedical Sciences for discovery of the mTOR (
mechanistic target of rapamycin) cellular pathway
as a key regulator of growth and metabolism in response to nutrients.